Healingcross Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 0.19 M
as on 28-12-2024
- Company Age 25 Year,
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 M
as on 28-12-2024
- Revenue -48.61%
(FY 2016)
- Profit -40.05%
(FY 2016)
- Ebitda -66.89%
(FY 2016)
- Net Worth -12.36%
(FY 2016)
- Total Assets -13.10%
(FY 2016)
About Healingcross Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 0.19 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shankar Srinivasan and Srinivas Hariharan serve as directors at the Company.
- CIN/LLPIN
U24239MH2000PTC123771
- Company No.
123771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Healingcross Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar Srinivasan  | Director | 21-Mar-2016 | Current |
| Srinivas Hariharan | Director | 21-Mar-2016 | Current |
Financial Performance of Healingcross Pharma.
Healingcross Pharma Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 48.61% decrease. The company also saw a substantial fall in profitability, with a 40.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healingcross Pharma?
In 2016, Healingcross Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orion Life Sciences LlpActive 11 years 10 monthsShankar Srinivasan and Srinivas Hariharan are mutual person
- Advanced Remedies LlpActive 8 years 10 months
Shankar Srinivasan and Srinivas Hariharan are mutual person
- One World Pharma LlpActive 6 years 1 month
Shankar Srinivasan and Srinivas Hariharan are mutual person
- Uni World Pharma Private LimitedActive 24 years 1 month
Shankar Srinivasan and Srinivas Hariharan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Credit Lyonnias Creation Date: 18 Mar 2002 | ₹7.50 M | Satisfied |
How Many Employees Work at Healingcross Pharma?
Unlock and access historical data on people associated with Healingcross Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healingcross Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healingcross Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
